6.12
+1.41%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Inogen
From its filings with the US Securities and Exchange Commission
Inogen is based in Beverly, Massachusetts and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker INGN. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $348.7m and a net loss of $22.7m. At that date it held total assets of $298.6m and shareholders' equity of $192.2m. By region, UNITED STATES accounted for 60.2%, followed by Non-US [Member] at 39.8%.
Inogen, Inc. is a medical technology business that primarily focuses on respiratory health. We develop, manufacture, and market innovative respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox® product for airway clearance treatment. In addition, we have started distributing the Inogen Voxi® 5 stationary oxygen concentrator as well as the Aurora® continuous positive airway pressure, or CPAP, masks in the United States. Our proprietary Inogen One® and Inogen Rove® POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. While often used together with stationary oxygen concentrators and oxygen compressed gas tanks, our POCs are designed to reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen, thereby improving patient quality of life and fostering mobility. Our Simeox product is a technology-enabled mucus management device predominantly aimed at serving patients requiring airway clearance, such as those with bronchiectasis – a condition characterized by damaged and widened bronchi that can occur in patients with cystic fibrosis, chronic obstructive pulmonary disease, or COPD, or other chronic respiratory diseases.
Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 14 Feb 2014
- Employees
- 753
- Website
- inogen.com ↗
- Head office
- 500 CUMMINGS CENTER, BEVERLY, MA, 01915
- Incorporated in
- DE
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Ms. Elizabeth MoraIndependent Chairman of the Board$312,910
- Mr. Kevin SmithPresident, Chief Executive Officer, Director, since 2023$4.2m
- Mr. Michael BourqueChief Financial Officer, Executive Vice President, Corporate Treasurer$1.9m
- Ms. Jennifer BoyerChief Human Resources Officer, Executive Vice President - Enterprise Enablement
- Mr. Kevin SmithExecutive Vice President - Business Development, General Counsel, Secretary$977,991
- Mr. Gregoire RamadeExecutive Vice President, Chief Commercial Officer$872,958
- Mr. Naga RameswamyChief Technology Officer
- Mr. Glenn BoehnleinIndependent Director$249,998
- Mr. Kevin KingIndependent Director$245,822
- Ms. Mary LadoneIndependent Director$248,762
- Ms. Heather RiderIndependent Director$242,498
- Ms. Mira SahneyIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 72
- Environment
- 68
- Social
- 99
- Governance
- 50
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Inogen Inc possesses several strengths that contribute to its success:
- Innovative Products: Inogen has a strong track record of developing and commercializing innovative oxygen therapy products, such as portable oxygen concentrators, which have revolutionized the industry.
- Strong Brand Reputation: The company has built a reputable brand known for its reliability, quality, and customer satisfaction, leading to a loyal customer base.
- Wide Market Presence: Inogen has established a strong market presence globally with its products available in multiple regions, allowing for diversified revenue streams.
Weaknesses
- Inogen Inc also faces certain weaknesses that need to be addressed:
- Dependence on Medicare Reimbursements: The company relies heavily on Medicare reimbursements for a significant portion of its revenue, which exposes it to changes in Medicare policies or reimbursement rates.
- Limited Product Portfolio: Inogen's product range is focused on oxygen therapy, which makes the company vulnerable to market fluctuations and increases competition in the narrow segment.
- Manufacturing Challenges: The company outsources its manufacturing, which presents potential risks related to quality control, supply chain disruptions, and increased costs.
Opportunities
- Inogen Inc can leverage the following opportunities to further grow its business:
- Aging Population: With the global population aging, there is an increasing demand for oxygen therapy products, offering potential for market expansion.
- International Expansion: Inogen can explore untapped markets and expand its global footprint, diversifying its revenue sources and reducing dependence on specific regions.
- Technological Advancements: The rapid advancement in technology opens up opportunities for the development of new and improved oxygen therapy products, allowing Inogen to stay ahead of the competition.
Threats
- Inogen Inc should be wary of the following threats that could impact its business:
- Regulatory Challenges: The company operates in a highly regulated industry, and any changes to government regulations or compliance requirements can significantly impact its operations and profitability.
- Competitive Landscape: The oxygen therapy market is becoming increasingly competitive, with the entry of new players and existing competitors offering alternative solutions that may erode Inogen's market share.
- Economic Factors: Economic downturns, fluctuations in exchange rates, or changes in healthcare spending can affect demand for Inogen's products and overall financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.